ImmunoPharm (Italics version) Flashcards

1
Q

🎵 “Etanercept blocks the flame,
(—) -alpha is its name.
Secukinumab fights IL-(——–),
Keeps your joints nice and clean.
Ustekinumab takes on two,
Twelve and twenty-three—it’ll do.
Tocilizumab calms the mix,
By shutting down IL number six.” 🎵

A

🎵 “Etanercept blocks the flame,
TNF-alpha is its name.
Secukinumab fights IL-seventeen,
Keeps your joints nice and clean.
Ustekinumab takes on two,
Twelve and twenty-three—it’ll do.
Tocilizumab calms the mix,
By shutting down IL number six.” 🎵

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

🎵 “Etanercept blocks the flame,
TNF-alpha is its name.
Secukinumab fights IL-seventeen,
Keeps your joints nice and clean.
(———-) takes on two,
Twelve and twenty-(—–) —it’ll do.
Tocilizumab calms the mix,
By shutting down IL number six.” 🎵

A

🎵 “Etanercept blocks the flame,
TNF-alpha is its name.
Secukinumab fights IL-seventeen,
Keeps your joints nice and clean.
Ustekinumab takes on two,
Twelve and twenty-three—it’ll do.
Tocilizumab calms the mix,
By shutting down IL number six.” 🎵

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

🎵 “Etanercept blocks the flame,
TNF-alpha is its name.
Secukinumab fights IL-seventeen,
Keeps your joints nice and clean.
Ustekinumab takes on two,
Twelve and twenty-three—it’ll do.
Tocilizumab calms the mix,
By shutting down IL number (—-).” 🎵

A

🎵 “Etanercept blocks the flame,
TNF-alpha is its name.
Secukinumab fights IL-seventeen,
Keeps your joints nice and clean.
Ustekinumab takes on two,
Twelve and twenty-three—it’ll do.
Tocilizumab calms the mix,
By shutting down IL number six.” 🎵

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is passive, selective antibody therapy?

A

Treatment with pre-formed antibodies from a donor that targets a specific antigen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Intravenous Immunoglobulin Therapy (IVIg)?

A

A therapy that involves administering antibodies to treat various conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name two types of antibodies that can be used in passive antibody therapy.

A
  • Antibodies against pathogens (e.g., botulism, measles)
  • Antibodies against hormones/receptors (e.g., herceptin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is etanercept (Enbrel)?

A

An anti-TNFalpha antibody used to block pro-inflammatory cytokines that help w/destruction of cells.

monoclonal antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What conditions is etanercept (Enbrel) used to treat?

A

Moderate to severe rheumatoid arthritis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some pharmacotoxicology risks associated with monoclonal antibodies?

A
  • Increased risk of infections (e.g., tuberculosis)
  • Reactivation of hepatitis B
  • Increased risk of certain cancers
  • Compromised therapeutic effects of vaccines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is secukinumab (Cosentyx)?

A

An anti-IL-17A monoclonal antibody used to block pro-inflammatory cytokines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the primary use of secukinumab (Cosentyx)?

A

Treatment of psoriasis and psoriatic arthritis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is ustekinumab (Stelara)?

A

An anti-IL-12 and IL-23 monoclonal antibody.

U get 2!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What conditions does ustekinumab (Stelara) treat?

A

Crohn’s Disease and Inflammatory Bowel Disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is tocilizumab (Actemra)?

A

An anti-IL-6 monoclonal antibody.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What conditions is tocilizumab (Actemra) used to treat?

A
  • Moderate to severe rheumatoid arthritis
  • COVID-19 illness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define ‘passive’ immunotherapy.

A

Non-antigen treatment that enhances an active acquired immune response without triggering it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is ‘passive, non-selective’ immunotherapy?

A

Treatment with cytokines or growth factors that enhance immune responses against any antigen.

18
Q

What is a monoclonal antibody?

A

An antibody made by cloning a single, unique antibody-forming cell (B-cell) that forms a single type of antibody.

19
Q

What are immunostimulants?

A

Substances that enhance the immune response

20
Q

What are examples of 2 passive, non-selective immunostimulants?

A

Granulocyte macrophage colony stimulating factor (GM-CSF)

& IL-2

21
Q

What conditions are treated with GM-CSF?

A

Immunodeficiency conditions associated with AIDS, radiation, and chemotherapy

22
Q

What is ‘passive, non-selective’ immunotherapy?

A

Treatment with cytokines or growth factors that enhance immune responses against any antigen

23
Q

What are hematopoietic growth factors?

A

Factors that act on stem cells in bone marrow

24
Q

Name the two functional categories of hematopoietic growth factors.

A
  • Pleiotropic/general growth factors
  • Lineage-specific growth factors
25
Q

What do pleiotropic/general growth factors like GM-CSF stimulate?

A

Multiple bone marrow lineages including eosinophils, monocytes, and neutrophils

26
Q

What is the function of lineage-specific growth factors like G-CSF?

A

Selectively stimulate the production of neutrophils

27
Q

What is interleukin 2 (IL-2) used to treat?

A

interleukin-2 is used in the treatment of immunodeficiency disorders

(often in combination with GM-CSF)

28
Q

What type of inhibitor is nivolumab?

A

anti-PD-1 inhibitor

Effective against melanoma, non-small cell carcinoma, pancreatic cancer, etc.

29
Q

What type of inhibitor is avelumab?

A

anti-PD-L1 inhibitor

Effective against melanoma, non-small cell carcinoma, pancreatic cancer, etc.

30
Q

What is the potential risk associated with the non-selective activation of cytotoxic T-cells?

A

Collateral autoimmune damage

The safety profile of these new medications seems acceptable.

31
Q

How do many forms of cancer evade detection by the immune system?

A

By producing inhibitory immune checkpoint proteins (ligands) that suppress immune functions.

32
Q

What happens when checkpoint proteins are triggered in cancer cells?

A

They switch off processes that activate T-cell attack of tumor cells.

33
Q

What is the revolutionary effect of immune checkpoint protein inhibitors in cancer therapy?

A

They ‘unmask’ cancer cells to cytotoxic T-cells, leading to their destruction.

34
Q

Fill in the blank: Many cancer cells express ligands for these ________ which suppress immune functions.

A

checkpoint receptors

35
Q

True or False: The safety profile of new checkpoint inhibitors is considered poor.

36
Q

Fill in the blank: nivolumab is a anti- ________ inhibitor effective against melanoma, non-small cell carcinoma, pancreatic cancer.

A

anti-PD-1 inhibitor

37
Q

What is ‘Active’ immunotherapy?

A

Antigen treatment that triggers an active acquired immune response in a patient.

The treatment involves administering the antigen and relying on the patient’s immune system to recognize and remember it.

38
Q

What is the goal of ‘Active’ immunotherapy?

A

To produce antibodies that recognize the antigen for a quick response in the future.

This approach primarily affects humoral immunity.

39
Q

What characterizes ‘Active, selective’ immunotherapy?

A

It triggers a response against a specific antigen.

This type of immunotherapy is focused on targeting a particular antigen.

40
Q

What characterizes ‘Active, non-selective’ immunotherapy?

A

It triggers a generalized response against more than one antigen.

This response is usually mediated by macrophages or natural killer cells.

41
Q

How does IL-2 work as an immunostimulant?

A

Interleukin-2 is a cytokine needed to activate an Acquired/Adaptive Immune response (AIR), activate those other immune cells, drawing them to the place of where the infection or immunogen is.

cyclosporine is an IL-2 inhibitor as an immunosuppressant, but we can use IL-2 as an immunostimulant